NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $365M
- YoY, 2025
- +6.1%
- 5-year CAGR
- +13.8%
- 10-year CAGR
- +23.2%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $365M | +6.1% |
| 2024 | $344M | +9.7% |
| 2023 | $314M | +1.1% |
| 2022 | $311M | +9.4% |
| 2021 | $284M | +48.2% |
| 2020 | $192M | +9.3% |
| 2019 | $175M | +53.5% |
| 2018 | $114M | +21.1% |
| 2017 | $94M | +7.4% |
| 2016 | $88M | +94.4% |
| 2015 | $45M | +26.2% |
| 2014 | $36M | +37.1% |
| 2013 | $26M | +11.9% |
| 2012 | $23M | +21.0% |
| 2011 | $19M | +2.9% |
| 2010 | $19M | — |